Absence of p18 mutations or deletions in lymphoid malignancies.

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Absence of p18 mutations or deletions in lymphoid malignancies.

Leukemia - 1 Feb 1996

Otsuki T, Jaffe E S, Wellmann A, Kumar S, Condron K S, Raffeld M

Abstract excerpt

p18 is a recently described cyclin-dependent kinase inhibitor (CDK-I) wih homology to p16 and p15. The latter two CDK-Is have been implicated as possible tumor suppressor genes in a wide variety of human tumors, including hematological malignancies. Because of p18's structural and functional homo...

Topics

Base Sequence
Carrier Proteins
Chromosomes, Human, Pair 1
Cyclin-Dependent Kinase Inhibitor p16
Cyclin-Dependent Kinases
Gene Deletion
Genes, Tumor Suppressor
Humans
Leukemia, Lymphoid
Lymphoma
Molecular Sequence Data
Mutation
Neoplasm Proteins
Polymerase Chain Reaction
Polymorphism, Single-Stranded Conformational
Sequence Homology, Nucleic Acid

Source

Open in PubMed

Identifiers

PMID: 8637248

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-8637248-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics